Home  /  Resource Library  /  Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (>70 y) with follicular lymphoma: a tertiary academic center experience

Balancing safety and efficacy of Bendamustine plus anti CD20 regimens in elderly patients (>70 y) with follicular lymphoma: a tertiary academic center experience

Study investigated doses of bendamustine for treatment of elderly patients with follicular lymphoma.